Yuan Wu - 论文、H指数与引用

Yuan Wu

duke university

27H指数

170论文数

2.5K被引数

收录论文 58

发表时间

Residual-based sieve maximum full likelihood estimation for the proportional hazards model 基于残差的筛子最大完全似然估计用于比例风险模型

COMMUNICATIONS IN STATISTICS-THEORY AND METHODS

IF0.8

2026-07-18

PREAI

Choi, Taehwa; Halabi, Susan; Kim, Hyotae; Wu, Yuan

Win Ratio as an Effect Size Measure Under Non-Proportional Hazards: A Comparison With Difference in Restricted Mean Survival 非比例风险下Win比率作为效应量测度：与限制平均生存时间差值的比较

Statistics in Medicine

IF1.8

2026-05-01

PREAI

Wu, Yuan; Wang, Xiaofei; Li, Zhiguo

Augmenter of liver regeneration alleviates lipid accumulation in MASLD through ATF3-CD36 axis 肝脏再生增强因子通过ATF3-CD36轴减轻MASLD中的脂质积累

Experimental Cell Research

IF3.5

2025-11-13

PREAI

Weichun Xiao; Yuan Wu; Ling Qin; Jing Zhang; Wei An

Causal relationship between plasma metabolites and hypertension: A Mendelian randomization study 血浆代谢物与高血压之间的因果关系：一项孟德尔随机化研究

MEDICINE

IF1.4

2025-10-03

PREAI

Yang, Fan; Wu, Yuan; Zhu, Haixiang; Ye, Xiaojian; Tang, Leiwen

Circulating immune biomarkers correlating with response in patients with metastatic renal cell carcinoma on immunotherapy 与转移性肾细胞癌患者免疫治疗反应相关的循环免疫标志物

JCI INSIGHT

IF6.1

2025-01-07

OAAI

Hwang, Joyce; Holl, Eda; Wu, Yuan; Agarwal, Anika; Starr, Mark D.; Martinez, Marco A. Reyes; Wang, Andrew Z.; Armstrong, Andrew J.; Harrison, Michael R.; George, Daniel J.; Nixon, Andrew B.; Zhang, Tian

IFNγ-secreting T cells that highly express IL-2 potently inhibit the growth of intracellular M. tuberculosis in macrophages

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-11-07

OAAI

Zhu, Liying; Wang, Bo; Gu, Jin; Zhou, Jiayu; Wu, Yuan; Xu, Wei; Yang, Min; Cai, Xia; Shen, Hongbo; Lu, Lu; Wang, Feifei

LncRNA SNHG16 Inhibits Intracellular M. tuberculosis Growth Involving Cathelicidin Pathway, Autophagy, and Effector Cytokines Production

ACS OMEGA

IF4.3

2024-10-10

OAAI

Huang, Guixian; Wu, Xiaocui; Ji, Xuejiao; Peng, Ying; Wang, Juechu; Cai, Xia; Wang, Yihui; Yang, Enzhuo; Zhu, Liying; Wu, Yuan; Sun, Qin; Shen, Ling; Sha, Wei; Shen, Hongbo; Wang, Feifei

Cytokeratin 18 in nonalcoholic fatty liver disease: value and application

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

IF3.6

2024-10-10

PREAI

Wu, Yuan; Zhou, Jing; Zhang, Jun; Li, Hongshan

Intensifying Salvage Therapy in Prostate-specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy with Apalutamide, Salvage Radiation, and Docetaxel: The Phase 2 STARTAR Trial 在根治性前列腺切除术后前列腺特异性抗原复发性前列腺癌中应用阿帕卢他胺、挽救性放疗和多西他赛强化挽救治疗：STARTAR II期临床试验

European Urology Oncology

IF9.3

2024-07-01

PREAI

Tian Zhang; Lauren Howard; Bridget F. Koontz; Scott T. Tagawa; Himanshu Nagar; Rhonda L. Bitting; Bart A. Frizzell; Luke Nordquist; Julia Rasmussen; Colleen Riggan; Marco Reyes; Catrin Davies; Steven R. Gray; Carly R. Newman; Escarleth Fernandez; Sundhar Ramalingam; Michael R. Harrison; Daniel J. George; Yuan Wu; Andrew J. Armstrong

Periostin facilitates ovarian cancer recurrence by enhancing cancer stemness

SCIENTIFIC REPORTS

IF3.9

2023-12-04

OAAI

Huang, Zhiqing; Byrd, Olivia; Tan, Sarah; Hu, Katrina; Knight, Bailey; Lo, Gaomong; Taylor, Lila; Wu, Yuan; Berchuck, Andrew; Murphy, Susan K.

Exploring optimal settings for safe and effective thulium fibre laser lithotripsy in a kidney model 在肾脏模型中探索安全有效的纤维激光碎石术的最佳设置

BJU INTERNATIONAL

IF4.4

2023-11-27

OAAI

Mishra, Arpit; Medairos, Robert; Chen, Junqin; Soto-Palou, Francois; Wu, Yuan; Antonelli, Jodi; Preminger, Glenn M.; Lipkin, Michael E.; Zhong, Pei

Efficacy and safety of trastuzumab with or without a tyrosine kinase inhibitor for HER2-positive breast cancer: A systematic review and meta-analysis

ANNALS OF ONCOLOGY

IF65.4

2023-10-01

OAAI

Li, L.; Zhang, D.; Wu, Y.; Ma, F.

Metabolomic characterization benefits the identification of acute lung injury in patients with type A acute aortic dissection

FRONTIERS IN MOLECULAR BIOSCIENCES

IF4

2023-08-03

OAAI

Fan, Linglin; Meng, Ke; Meng, Fanqi; Wu, Yuan; Lin, Ling

Development of an optically transparent kidney model for laser lithotripsy research

BJU INTERNATIONAL

IF4.4

2023-04-17

OAAI

Tran, Sabrina; Chen, Junqin; Kozel, Gunnar; Chang, Eric T.; Phung, Trina; Peng, Yanxi; Dionise, Zachary; Wu, Yuan; Simmons, W. Neal; Lipkin, Michael E.; Preminger, Glenn M.; Zhong, Pei

A novel method for detection of ochratoxin A in foods-Co-MOFs based dual signal ratiometric electrochemical aptamer sensor coupled with DNA walker

FOOD CHEMISTRY

IF9.8

2023-03-01

PREAI

Guan, Yan; Si, Peng-Bin; Yang, Tong; Wu, Yuan; Yang, Yun-Hui; Hu, Rong

An integrated magneto-fluorescent nanosensor for rapid and sensitive detection of tumor-derived exosomes

SENSORS AND ACTUATORS B-CHEMICAL

IF7.7

2023-01-01

PREAI

Luo, Shihua; Wu, Yuan; Pan, Weilun; Zhong, Guangzhi; Situ, Bo; Li, Bo; Ye, Xinyi; Jiang, Xiujuan; Li, Wenbin; Zhang, Ye; Zheng, Lei; Wang, Qian

Platelet RNA enables accurate detection of ovarian cancer: an intercontinental, biomarker identification study

PROTEIN & CELL

IF12.8

2022-11-10

OAAI

Gao, Yue; Liu, Chun-Jie; Li, Hua-Yi; Xiong, Xiao-Ming; Li, Gui-Ling; In't Veld, Sjors G. J. G.; Cai, Guang-Yao; Xie, Gui-Yan; Zeng, Shao-Qing; Wu, Yuan; Chi, Jian-Hua; Liu, Jia-Hao; Zhang, Qiong; Jiao, Xiao-Fei; Shi, Lin-Li; Lu, Wan-Rong; Lv, Wei-Guo; Yang, Xing-Sheng; Piek, Jurgen M. J.; de Kroon, Cornelis D.; Lok, C. A. R.; Supernat, Anna; Lapinska-Szumczyk, Sylwia; Lojkowska, Anna; Zaczek, Anna J.; Jassem, Jacek; Tannous, Bakhos A.; Sol, Nik; Post, Edward; Best, Myron G.; Kong, Bei-Hua; Xie, Xing; Ma, Ding; Wurdinger, Thomas; Guo, An-Yuan; Gao, Qing-Lei

Tetrahedral framework nucleic acids linked CRISPR/Cas13a signal amplification system for rare tumor cell detection

TALANTA

IF6.1

2022-09-01

PREAI

Li, Kerun; Luo, Shihua; Guan, Shujuan; Situ, Bo; Wu, Yuan; Ou, Zihao; Tao, Maliang; Zheng, Lei; Cai, Zhen

Ultrasensitive dual-signal electrochemical ratiometric aptasensor based on Co-MOFs with intrinsic self-calibration property for Mucin 1

ANALYTICA CHIMICA ACTA

IF6

2022-09-01

PREAI

Xie, Fa-Ting; Li, Yu-Long; Guan, Yan; Liu, Jia-Wen; Yang, Tong; Mao, Guo-Jiang; Wu, Yuan; Yang, Yun-Hui; Hu, Rong

Is time to castration resistant prostate cancer a potential intermediate end-point for time to metastasis among men initiating androgen deprivation therapy for non-metastatic prostate cancer with rapid PSA doubling time (<9 months)?

PROSTATE CANCER AND PROSTATIC DISEASES

IF5.8

2022-09-01

PREAI

Klaassen, Zachary; Howard, Lauren; Wallis, Christopher J. D.; Janes, Jessica L.; De Hoedt, Amanda; Aronson, William J.; Polascik, Thomas J.; Amling, Christopher J.; Kane, Christopher J.; Cooperberg, Matthew R.; Terris, Martha K.; Wu, Yuan; Freedland, Stephen J.

研究方向